Terms: = Thyroid cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
87 results:
1. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for cancer treatment - Pharmacology and Mechanisms.
Xing Z; Su A; Mi L; Zhang Y; He T; Qiu Y; Wei T; Li Z; Zhu J; Wu W
Drug Des Devel Ther; 2023; 17():2909-2929. PubMed ID: 37753228
[TBL] [Abstract] [Full Text] [Related]
2. Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer.
Yun HJ; Lee JS; Lee JS; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2023; 14():1166640. PubMed ID: 37424860
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related thyroid Dysfunction.
Zhang Q; Jiao X; Lai X
J Clin Endocrinol Metab; 2023 Oct; 108(11):2916-2923. PubMed ID: 37183427
[TBL] [Abstract] [Full Text] [Related]
4. First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC).
Autio KA; Higano CS; Nordquist L; Appleman LJ; Zhang T; Zhu XH; Babiker H; Vogelzang NJ; Prasad SM; Schweizer MT; Madan RA; Billotte S; Cavazos N; Bogg O; Li R; Chan K; Cho H; Kaneda M; Wang IM; Zheng J; Tang SY; Hollingsworth R; Kern KA; Petrylak DP
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36948505
[TBL] [Abstract] [Full Text] [Related]
5. Hodgkin Lymphoma in Children and Adolescents of Northern Greece: 25-Year Results and Long-term Follow-up.
Kourti M; Papakonstantinou E; Papagianni A; Arsos G; Ioannidou M; Pantoleon A; Antari V; Palabougiouki M; Kouskouras K; Venizelos I; Κoletsa T; Cheva A; Anastasiou A; Totikidis G; Tragiannidis A; Galli-Tsinopoulou A; Hatzipantelis E
J Pediatr Hematol Oncol; 2023 Aug; 45(6):322-326. PubMed ID: 36716084
[TBL] [Abstract] [Full Text] [Related]
6. NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology.
Agaimy A; Brcic L; Briski LM; Hung YP; Michal M; Michal M; Nielsen GP; Stoehr R; Rosenberg AE
Genes Chromosomes Cancer; 2023 May; 62(5):256-266. PubMed ID: 36524687
[TBL] [Abstract] [Full Text] [Related]
7. Does transitory steroid-induced central hypothyroidism in children treated for haematological malignancies warrant clinical intervention?
Kranjčec I; Matijašić N; Oletić L; Grizelj A; Štromar L
Pediatr Endocrinol Diabetes Metab; 2022; 28(4):245-249. PubMed ID: 35942829
[TBL] [Abstract] [Full Text] [Related]
8. Development of hypothyroidism over 13 years of follow-up of patients with hyperthyroidism after radioiodine therapy.
Li JF; Xie LJ; Qin LP; Wan QC; Li JP; Wu QY; Cheng MH
Hell J Nucl Med; 2022; 25(1):26-31. PubMed ID: 35388801
[TBL] [Abstract] [Full Text] [Related]
9. Measurement of neutron equivalent dose in the thyroid, chiasma, and lens for patients undergoing pelvic radiotherapy: A phantom study.
Shojaei M; Rashedi S; Chakoli AN; Karimi AH; Geraily G
Appl Radiat Isot; 2022 Jun; 184():110188. PubMed ID: 35358808
[TBL] [Abstract] [Full Text] [Related]
10. thyroid DISEASE IN THE LATE OBSERVATION PERIOD UPON CHEMO AND RADIOTHERAPY IN CHILDREN/SURVIVORS OF ACUTE LYMPHOBLASTIC LEUKEMIA.
Bebeshko VG; Bruslova KM; Lyashenko LO; Tsvіetkova NM; Galkina SG; Yaroshenko ZS; Gonchar LO; Boyarska OY; Kuzmenko VF; Trykhlib IV; Kavardakova NV
Probl Radiac Med Radiobiol; 2021 Dec; 26():309-318. PubMed ID: 34965557
[TBL] [Abstract] [Full Text] [Related]
11. Change in worry over time among Hispanic women with thyroid cancer.
Jackson Levin N; Zhang A; Reyes-Gastelum D; Chen DW; Hamilton AS; Zebrack B; Haymart MR
J Cancer Surviv; 2022 Aug; 16(4):844-852. PubMed ID: 34633638
[TBL] [Abstract] [Full Text] [Related]
12. Health-Related Quality of Life in Asian Differentiated thyroid cancer Survivors.
Chan WL; Choi HC; Lang B; Wong KP; Yuen KK; Lam KO; Lee VH; Kwong D
Cancer Control; 2021; 28():10732748211029726. PubMed ID: 34189945
[TBL] [Abstract] [Full Text] [Related]
13. Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation.
Fu YH; Ou DL; Yang YR; Su KW; Chen CY; Tien HF; Lai ZS; Shen CJ; Chien HF; Lin LI
Cancer Gene Ther; 2022 Jun; 29(6):784-792. PubMed ID: 34117374
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of surveillance for late effects of bcr-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias.
Smith SM; Sabnis HS; Lewis RW; Effinger KE; Bergsagel J; Patterson B; Mertens A; Sakamoto KM; Schapira L; Castellino SM
BMC Cancer; 2021 Apr; 21(1):474. PubMed ID: 33926411
[TBL] [Abstract] [Full Text] [Related]
15. thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor treatment.
Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
[TBL] [Abstract] [Full Text] [Related]
16. Nilotinib, A Tyrosine Kinase Inhibitor, Suppresses the Cell Growth and Triggers Autophagy in Papillary thyroid cancer.
Meng L; Zhao P; Hu Z; Ma W; Niu Y; Su J; Zhang Y
Anticancer Agents Med Chem; 2022; 22(3):596-602. PubMed ID: 33797387
[TBL] [Abstract] [Full Text] [Related]
17. Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update.
Roskoski R
Pharmacol Res; 2021 Mar; 165():105463. PubMed ID: 33513356
[TBL] [Abstract] [Full Text] [Related]
18. A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation treatment in Low- to Intermediate-Risk of Papillary thyroid cancer: The MOREthyroid Trial Protocol.
Lee EK; Lee YJ; Park YJ; Moon JH; Yi KH; Kim KS; Lee JH; Cho SW; Joo J; Hwangbo Y; Go S; Park DJ
Endocrinol Metab (Seoul); 2020 Sep; 35(3):571-577. PubMed ID: 32981299
[TBL] [Abstract] [Full Text] [Related]
19. Quality of Life in Papillary thyroid Microcarcinoma Patients Undergoing Radiofrequency Ablation or Surgery: A Comparative Study.
Lan Y; Luo Y; Zhang M; Jin Z; Xiao J; Yan L; Zhu Y
Front Endocrinol (Lausanne); 2020; 11():249. PubMed ID: 32499754
[No Abstract] [Full Text] [Related]
20. [Detection rate of thyroid nodules in routine health check-up and its influencing factors: a 10-year survey of 309 576 cases].
Lai X; Ouyang P; Zhu H; An S; Xia L; Yao Y; Zhang H; Li Z; Deng K
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb; 40(2):268-273. PubMed ID: 32376525
[TBL] [Abstract] [Full Text] [Related]
[Next]
